Table 3.

International recommendations and the specific patient populations that could benefit from antiviral therapies in the UAE

Specialism	Which patients would you treat?	What guideline(s) do you follow?
Cardiology	Patients at high risk	ACC [52]; ESC [53]
Endocrinology	Patients at high risk with (uncontrolled) diabetes	CDC [55] and UAE guidelines
Internal medicine	Patients with a moderate to severe infection Patients at high risk with mild to moderate symptoms	US and local UAE guidelines
Obstetrics and gynecology	Case-by-case decision made with an infectious disease specialist during the second and third trimester	Local guidelines RCOG, and WHO recommendation [49]
Oncology	All patients with cancer who are immunocompromised	NCCN [5]; ESMO
Pediatrics	High risk > 28 days	Local guideline
Primary care	Patients at high risk	Not stated
Public health	N/A	N/A

ACC American College of Cardiology, CDC Centers for Disease Control and Prevention, ESC European Society of Cardiology, ESMO European Society for Medical Oncology, N/A not applicable, RCOG Royal College of Obstetricians and Gynaecologists, UAE United Arab Emirates, US United States